Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway.
Saved in:
| Title: | Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway. |
|---|---|
| Authors: | Premkumar DR; Department of Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA., Jane EP, Foster KA, Pollack IF |
| Source: | The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2013 Aug; Vol. 346 (2), pp. 201-10. Date of Electronic Publication: 2013 Jun 05. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
